Allicin inhibits kidney stone formation by suppressing the TNF/NF-κB pathway: Experimental validation through network pharmacology, in vitro, and in vivo studies
Zechun Peng, Mingbin Xu, Jie Yang, Shuming He · 2026
Read Allicin inhibits kidney stone formation by suppressing the TNF/NF-κB pathway: Experimental validation through network pharmacology, in vitro, and in vivo studies by Zechun Peng, Mingbin Xu, Jie Yang, Shuming He (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13253885.txt.
Description
Zechun Peng and colleagues test allicin, a compound from garlic, against kidney stones in a 2026 study. Kidney stones are common and often return. The team combined computer-based target hunting, cell tests on harmed kidney cells, and a rat model where stones were induced with a chemical.
Computer screening found 46 shared targets between allicin and stone disease, with TNF as the central one. In cells, allicin raised survival and cut inflammatory factors. In rats, it reduced kidney damage and calcium oxalate deposits. The authors say it works by blocking the TNF/NF-κB pathway, a chain of signals that drives swelling.
Catalog record
| CREATOR | Zechun Peng, Mingbin Xu, Jie Yang, Shuming He |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34797 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |